HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT
Clinical trial NCT05166239 · COMPLETED
Trial details
- NCT number
- NCT05166239
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-10
- Primary completion
- 2023-12-29
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.